The ERAS Protocol: What the Evidence Shows About Post-Operative Recovery
A synthesis of 74+ randomised trials and cross-specialty meta-analyses examining how Enhanced Recovery After Surgery protocols reduce hospital stay, lower complication rates, and reshape perioperative care — through 2025.
This is an original evidence synthesis. See References for source studies.
One-Minute Takeaway
One-Minute Takeaway
- The largest meta-analysis to date (Sauro et al. 2024; 74 RCTs, 9,076 patients) provides strong evidence that ERAS protocols reduce hospital length of stay by approximately 1.9 days and lower complication risk by 29% across nine surgical specialties, without increasing readmission or mortality.
- Specialty-specific meta-analyses consistently demonstrate similar benefits: colorectal surgery (3–8 days reduction in stay), hepatic surgery (2.2 days reduction with 29% fewer complications), and pancreatic surgery (2.5 days reduction with significant cost savings).
- A dose-response relationship has been identified: higher compliance with ERAS elements is associated with greater reductions in length of stay and complications, yet average compliance across trials remains moderate at approximately 75%.
- Implementation remains the primary barrier — knowledge gaps, resource constraints, lack of institutional support, and multidisciplinary coordination challenges prevent many centres from achieving full ERAS adoption.
Why This Topic Matters
Since Henrik Kehlet first proposed a multimodal approach to perioperative care in the late 1990s, the philosophy behind Enhanced Recovery After Surgery has transformed from a niche academic concept into a global movement with dedicated society guidelines spanning over 15 surgical procedures. The central insight — that the surgical stress response can be systematically attenuated through coordinated preoperative, intraoperative, and postoperative interventions — challenges decades of traditional surgical dogma around fasting, bed rest, routine drainage, and opioid-heavy analgesia.
The clinical and economic implications are substantial. Postoperative complications remain a leading driver of healthcare expenditure globally, and prolonged hospital stays contribute to both patient morbidity and bed occupancy pressures. ERAS protocols address these challenges at scale, yet a persistent gap remains between the strength of the evidence supporting these pathways and their real-world adoption. Understanding both the benefits and the implementation challenges of ERAS is now essential for every surgical team.
What Evidence Was Reviewed
This synthesis draws upon the definitive 2024 JAMA Network Open meta-analysis of 74 RCTs, multiple specialty-specific systematic reviews and meta-analyses published between 2020 and 2025, ERAS Society guideline publications, and implementation science studies examining compliance and barriers. The evidence base spans colorectal, hepatobiliary, pancreatic, orthopaedic, gynaecological, cardiac, and emergency surgery. Priority is given to RCT-level evidence and meta-analyses using GRADE methodology.
| Study | Design | n | Population | Key Finding | Quality |
|---|---|---|---|---|---|
| Sauro et al. 2024 (JAMA) | MA of 74 RCTs | 9076 | 9 surgical specialties | LOS reduced 1.88 days; complications reduced 29%; no increase in readmission | High |
| SR colorectal 2025 (11 RCTs) | SR of RCTs | 1476 | Colorectal surgery | LOS reduction 3–8 days; improved recovery; no mortality difference | High |
| Colorectal MA 2024 (12 RCTs) | MA of 12 RCTs | 1920 | Colorectal surgery | LOS reduced 4.12 days; complications OR 0.42 (p < 0.0001) | High |
| Pancreatic MA 2025 (7 RCTs) | MA of 7 RCTs | 731 | Pancreatic surgery | LOS reduced 2.49 days; hospital costs significantly lower | Moderate |
| Liver surgery MA 2020 | MA (6 RCTs + 21 cohorts) | 3739 | Hepatectomy | LOS reduced 2.22 days; complications RR 0.71; costs lower | Moderate |
| Hip surgery MA 2025 | MA of RCTs + observational | NR | Orthopaedic hip surgery | Reduced LOS, time to surgery, and complications; no mortality difference | Moderate |
| Cesarean SR/MA 2024 | SR/MA (3 RCTs + 13 cohorts) | 19001 | Cesarean delivery | Reduced LOS and opioid use; no increase in maternal complications | Moderate |
| GI surgery MA 2025 | MA (6 RCTs + 7 cohorts) | 5603 | Gastrointestinal surgery | Reduced LOS and complications; no difference in readmission/mortality | Moderate |
| ERAS Gynecologic Oncology Guidelines 2023 | Guideline (GRADE) | NR | Gynecologic oncology | LOS reduced 1.6 days; 32% fewer complications; dose-response with compliance | High |
| Emergency laparotomy MA 2024 | MA of RCTs | NR | Emergency laparotomy | ERAS feasible in emergency settings with similar benefits | Low |
| ERATIC Guidelines 2025 | Consensus guideline | NR | Trauma surgery/ICU | ERAS principles applicable to trauma; challenges remain in implementation | Low |
Key Findings on ERAS Protocols: Synthesised by Theme
Hospital Length of Stay: Consistent Reductions Across All Specialties
The most robust and reproducible outcome in the ERAS literature is the reduction in hospital length of stay. The landmark Sauro et al. meta-analysis of 74 RCTs with 9,076 participants across nine surgical specialties found that ERAS-guided care reduced hospital stay by an average of 1.88 days (95% CI 0.95–2.81, p < 0.001) compared with conventional care. Postoperative length of stay specifically was reduced by 2.8 days.
The magnitude of this benefit varies by surgical complexity. In colorectal surgery — the most extensively studied specialty — reductions range from 3 to 8 days depending on the specific studies, with a pooled estimate from one 2024 meta-analysis of 12 RCTs (1,920 patients) showing a 4.12-day reduction in overall stay (95% CI 2.38–5.86, p = 0.00001). In pancreatic surgery, where postoperative stays are traditionally longer, ERAS was associated with a 2.49-day reduction (95% CI 0.79–4.20, p < 0.01). Even in caesarean delivery — a procedure with an already short baseline stay — ERAS implementation produced meaningful reductions in both length of stay and postoperative opioid consumption.
Complication Rates: Significant Reductions Without Safety Trade-Offs
The Sauro et al. meta-analysis demonstrated a 29% reduction in the risk of 30-day complications with ERAS implementation (RR 0.71, 95% CI 0.59–0.87, p < 0.001). This finding aligns with specialty-specific data: in colorectal surgery, one meta-analysis of 12 RCTs reported a complication OR of 0.42 (95% CI 0.27–0.65, p < 0.0001), while in hepatic surgery the pooled complication risk ratio was 0.71 (95% CI 0.65–0.77, p < 0.00001). Critically, these complication reductions are achieved without a corresponding increase in readmission rates or mortality — a concern that initially hindered ERAS adoption among sceptical clinicians.
The mechanisms behind these reductions are multifactorial. ERAS pathways simultaneously target several modifiable risk factors for complications: dehydration (through goal-directed fluid therapy), immobility (through early mobilisation), gut dysfunction (through early oral nutrition and reduced opioid use), and surgical site infection (through normothermia and antibiotic prophylaxis protocols). The evidence supports the view that these elements work synergistically rather than independently, which explains why higher overall compliance produces greater benefits.
Core ERAS Components: What the Evidence Supports
Modern ERAS protocols encompass a coordinated set of preoperative, intraoperative, and postoperative elements. The Sauro et al. meta-analysis found that trials incorporated a mean of 11.1 ERAS elements. The most commonly implemented were early mobilisation, structured postoperative analgesia management (particularly multimodal opioid-sparing approaches), postoperative dietary and bowel management, and drain and tube management. Across ERAS Society guidelines, the core evidence-based components can be grouped into three phases.
Evidence-based preoperative elements include structured patient education and expectation setting, which reduces anxiety and improves cooperation with postoperative goals. Nutritional screening and intervention — particularly carbohydrate loading 2–3 hours before surgery — has been shown to reduce postoperative insulin resistance and shorten fasting periods compared with the traditional midnight-nil-by-mouth approach. Prehabilitation programmes incorporating exercise, nutritional, and psychological support are increasingly incorporated, particularly for patients undergoing major cancer surgery. Smoking and alcohol cessation programmes initiated at least 4 weeks preoperatively are associated with reduced wound and pulmonary complications.
Intraoperative ERAS elements focus on attenuating the physiological insult of surgery. Minimally invasive surgical techniques (laparoscopic or robotic) reduce tissue trauma and inflammatory response. Goal-directed fluid therapy, guided by haemodynamic monitoring rather than fixed-volume protocols, helps avoid both hypovolaemia and fluid overload — both of which contribute to postoperative complications. Active temperature management (maintaining operating room temperature ≥21°C plus forced-air warming) prevents perioperative hypothermia, which is associated with impaired wound healing and increased infection risk. Multimodal anaesthetic approaches incorporating regional techniques, short-acting agents, and avoidance of high-dose opioids lay the foundation for the opioid-sparing postoperative pathway.
The postoperative phase is where ERAS most visibly diverges from traditional care. Early oral nutrition — often within hours of surgery rather than waiting for bowel sounds or flatus — is supported by strong evidence showing no increase in anastomotic leak risk and improved gut function recovery. Multimodal analgesia using scheduled paracetamol, NSAIDs, and regional techniques as first-line therapy, with opioids reserved as rescue medication, reduces opioid-related side effects (sedation, nausea, ileus) while maintaining adequate pain control. Early mobilisation protocols target patients being out of bed within hours of surgery, with progressive daily activity goals. Selective rather than routine use of nasogastric tubes, drains, and urinary catheters removes barriers to ambulation and eliminates catheter-associated infections. Structured discharge criteria based on functional recovery milestones rather than arbitrary time thresholds enable safe earlier discharge.
ERAS principles were originally developed for elective colorectal surgery, but the evidence base has expanded substantially. The ERAS Society now publishes guidelines for over 15 procedures, and the concept is being adapted to increasingly complex and acute settings. A 2024 meta-analysis demonstrated feasibility and benefit of ERAS in emergency laparotomy, while the 2025 ERATIC guidelines represent the first formal attempt to apply ERAS principles to trauma and intensive care settings. In caesarean delivery, ERAS implementation in over 19,000 women was associated with reduced length of stay and opioid consumption without increasing maternal or neonatal complications. Cardiac surgery and craniotomy ERAS programmes are also showing early promise in reducing postoperative stay and complication rates.
Implementation Challenges: The Evidence-to-Practice Gap
Perhaps the most important finding across the ERAS literature is not clinical but operational: the persistent gap between what ERAS protocols recommend and what is actually delivered at the bedside. Across the 74 RCTs in the Sauro meta-analysis, mean compliance was 74.7% — and real-world compliance outside of trial settings is typically lower. Studies from France and Turkey have identified compliance rates ranging from as low as 15% for individual components (such as avoiding routine nasogastric tubes) to around 60% overall in non-trial settings.
The barriers are multi-layered. Survey-based research identifies recurring themes: insufficient awareness that ERAS guidelines exist for a given procedure, lack of dedicated resources (ERAS coordinators, audit infrastructure), absence of institutional leadership support, and the inherent difficulty of coordinating behaviour change across multiple professional groups — surgeons, anaesthesiologists, nurses, physiotherapists, and dietitians — who each operate within their own clinical cultures. Centres that have succeeded in sustaining high ERAS compliance consistently report that audit-and-feedback systems and dedicated ERAS coordinators are essential.
Quality & Consistency of Evidence
What the Evidence Does Not Show
Despite the breadth of evidence supporting ERAS, several clinically relevant questions lack definitive answers from high-quality randomised research.
The relative contribution of individual ERAS elements remains poorly understood. Because ERAS is a bundled intervention, it is methodologically difficult to isolate which components drive the observed benefits. The Sauro meta-analysis noted that the type of surgery and the number of ERAS elements were associated with differences in length-of-stay estimates, but no trial has systematically deconstructed the pathway to determine which elements are essential versus supplementary.
Long-term patient-reported outcomes are largely absent from the literature. While length of stay and 30-day complications are well-characterised, data on functional recovery at 3–6 months, quality of life, chronic pain outcomes, and patient satisfaction with the accelerated recovery experience are sparse. Additionally, the optimal ERAS protocol for specific subpopulations — including frail elderly patients, individuals with significant comorbidities, and patients in resource-limited healthcare settings — has not been defined through dedicated randomised trials. The heterogeneity of ERAS protocol definitions across studies also complicates cross-trial comparisons.
Practical Implications
Based on the current evidence, the following considerations emerge for surgical teams and healthcare institutions.
Evidence Grade + Bottom Line
Overall Evidence Grade: Strong
The evidence supporting ERAS protocols is grounded in the largest meta-analysis of perioperative pathway RCTs ever conducted (74 trials, 9,076 patients), reinforced by specialty-specific meta-analyses with consistent results across colorectal, hepatobiliary, pancreatic, orthopaedic, gynaecological, and obstetric surgery. The core findings — reduced hospital stay and fewer complications without increased readmission — are unlikely to change with further research.
A "strong" evidence grade indicates that ERAS represents the current evidence standard for perioperative care across multiple surgical specialties. The primary challenge is no longer proving efficacy but achieving consistent, sustained implementation. Future research is expected to refine which elements matter most and how to tailor pathways for complex patient populations.
- ERAS protocols reduce hospital stay by approximately 2 days and complications by 29% across surgical specialties, supported by the largest meta-analysis of perioperative RCTs to date.
- These benefits are achieved without increasing readmission or mortality rates — the safety profile supports broader adoption.
- Higher compliance with ERAS elements produces greater improvements, establishing a clear dose-response relationship that rewards investment in implementation quality.
- Implementation remains the primary barrier: dedicated ERAS coordinators, audit systems, and institutional leadership commitment are essential for success.
- Evidence remains limited regarding the relative value of individual ERAS components, long-term patient-reported outcomes, and optimal protocols for frail, elderly, and emergency populations.
Article Information
For Educational Purposes Only. This is an original evidence synthesis informed by the studies listed below. It does not replace clinical judgement. Drug dosages should be verified against current prescribing information.
References
- Sauro KM, Smith C, Ibadin S, et al. Enhanced recovery after surgery guidelines and hospital length of stay, readmission, complications, and mortality: a meta-analysis of randomized clinical trials. JAMA Netw Open. 2024;7(6):e2417310. DOI: 10.1001/jamanetworkopen.2024.17310
- Abdelrahman I, Al-Zawi A, Alhayki R, et al. Impact of ERAS protocols vs. traditional perioperative care on patient outcomes after colorectal surgery: a systematic review. Patient Saf Surg. 2025;19:4. DOI: 10.1186/s13037-024-00425-9
- Alqarni A, Alobaidi N, Alosaimi S, et al. An evaluation of the effectiveness and safety of the ERAS program for patients undergoing colorectal surgery: a meta-analysis of randomized controlled trials. Pol Przegl Chir. 2024;96(1):73–83. DOI: 10.5604/01.3001.0053.9570
- Merza N, et al. Effectiveness of Enhanced Recovery After Surgery (ERAS) protocol in pancreatic surgery: a systematic review and meta-analysis of RCTs. J Gastrointest Surg. 2025. DOI: 10.1016/j.gassur.2024.12.015
- Noba L, Wakefield S, et al. Enhanced Recovery After Surgery (ERAS) reduces hospital costs and improves clinical outcomes in liver surgery: a systematic review and meta-analysis. J Gastrointest Surg. 2020;24(5):1128–1137. DOI: 10.1007/s11605-019-04499-0
- Pinho B, Costa A. Impact of enhanced recovery after surgery (ERAS) guidelines implementation in cesarean delivery: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2024;292:201–209. DOI: 10.1016/j.ejogrb.2023.11.025
- Nelson G, Bakkum-Gamez JN, Kalogera E, et al. Enhanced recovery after surgery (ERAS) society guidelines for gynecologic oncology: addressing implementation challenges — 2023 update. Gynecol Oncol. 2023;173:58–73. DOI: 10.1016/j.ygyno.2023.04.009
- Hardcastle TC, et al. Guidelines for Enhanced Recovery After Trauma and Intensive Care (ERATIC): ERAS and IATSIC Society recommendations. World J Surg. 2025;49:2029–2054. DOI: 10.1002/wjs.70004
- Amir AH, Davey MG, Donlon NE. Evaluating the impact of enhanced recovery after surgery protocols following emergency laparotomy: a systematic review and meta-analysis of randomised clinical trials. Am J Surg. 2024;236:115857. DOI: 10.1016/j.amjsurg.2024.115857
- Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997;78(5):606–617. DOI: 10.1093/bja/78.5.606
- Özbay T, Şanlı D, Springer JE. An investigation on the compliance of perioperative practices using ERAS protocols and barriers to implementation in colorectal surgery. Acta Chir Belg. 2024;124(5):396–405. DOI: 10.1080/00015458.2024.2327813
- Kaya OA, et al. Implementation of ERAS protocols: in theory and practice. Turk J Anaesthesiol Reanim. 2024;52(5):343–349. DOI: 10.4274/TJAR.2024.241137
- Antoniv M, Nikiforchin A, Sell NM, et al. Impact of multi-institutional enhanced recovery after surgery protocol implementation on elective colorectal surgery outcomes. J Am Coll Surg. 2025;240(2):158–166. DOI: 10.1097/XCS.0000000000001185